HZNP

Q: What is the price of Horizon Therapeutics (HZNP) today?

The price of Horizon Therapeutics (HZNP) today is US$ 0,00, with a variation of 0% compared to the last year. The price of Horizon Therapeutics (HZNP) started the year trading around US$ 0,00 and today it is at US$ 0,00. Follow the real-time price chart, the historical price of Horizon Therapeutics (HZNP), and stock data from Ibovespa and international markets.

Q: When does Horizon Therapeutics (HZNP) pay dividends?

Horizon Therapeutics (HZNP) did not distribute dividends in the last year.

Q: Horizon Therapeutics (HZNP) is it worth it?

Currently, Horizon Therapeutics (HZNP) is priced at US$ 0,00, with a P/E of 62,12%, representing a deviation of 53,60% from its historical average P/E. In the last year, the stock showed a variation of 0% in its price and distributed US$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was 0,00%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy stocks of Horizon Therapeutics (HZNP)?

Investing in stocks of Horizon Therapeutics (HZNP) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 stocks of Horizon Therapeutics (HZNP) yield today?

The yield of Horizon Therapeutics (HZNP) was 0,00% in the last month, 0,00% in the last year and 0,00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of US$ 0,00 in dividends, um Dividend Yield de 0,00%.If you wanted to buy 100 stocks of Horizon Therapeutics (HZNP) today, the total investment would be US$ 0,00, based on the current price of US$ 0,00.If past performance were to repeat, the return on your investment would be:In 1 year: US$ 0,00In 5 years: US$ 0,00In 10 years: 0,00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Horizon Therapeutics Public Limited Company

Price

US$ -

variation (12m)

0,00%

p/l

62,12

p/vp

5,12

DIVIDEND YIELD

0,00%

price HZNP

BVMF

HZNP

If you had invested

years ago

6 months

1 year

5 years

10 years

ago, today you would have

ago, today you would have:

*The figure considers the reinvestment of dividends.

Profitability of HZNP

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

0,00%

3 months

0,00%

1 year

0,00%

2 years

0,00%

5 years

0,00%

10 years

0,00%

real profitability

profitability minus inflation.

1 month

0,00%

3 months

0,00%

1 year

0,00%

2 years

0,00%

5 years

0,00%

10 years

0,00%

Indicators HZNP

check out the fundamentals of Horizon Therapeutics shares

P/E

62,12

Sector: -3,47 Industry: -3,47

P/SALES RATIO (PSR)

7,47

Sector: -4,23 Industry: -4,23

P/BV

5,12

Sector: 1,89 Industry: 1,89

DIVIDEND YIELD (DY)

0,00%

Sector: - Industry: -

ROA

4,71%

Sector: -63,87% Industry: -63,87%

ROE

8,25%

Sector: -70,87% Industry: -70,87%

ROIC

Sector: -2.084,36% Industry: -2.084,36%

NET MARGIN

12,02%

Sector: -41,75% Industry: -41,75%

GROSS MARGIN

75,21%

Sector: 38,19% Industry: 38,19%

OPERATING MARGIN

14,09%

Sector: -41,04% Industry: -41,04%

P/EBITDA

53,19

Sector: -3,65 Industry: -3,65

P/EBIT

222,15

Sector: -3,64 Industry: -3,64

P/ASSET

2,93

Sector: 1,41 Industry: 1,41

BVPS

22,70

Sector: 1,84 Industry: 1,84

EPS

1,87

Sector: -2,20 Industry: -2,20

EQUITY / ASSETS

0,57

Sector: 0,42 Industry: 0,42

CAGR REVENUES 5 YEARS

10,62%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

2,36%

Sector: - Industry: -

FAIR PRICE OF Horizon Therapeutics ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 0,00

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

HZNP indicators history

DRAG THE FRAME TO SEE MORE DATA

Stocks comparator

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	net margin
JNJ	17,80	5,78	32,50%	2,69%	US$ 453,87 B	27,75%
PFE	16,92	1,75	10,33%	6,25%	US$ 155,60 B	15,13%
ABBV	108,79	-2.966,40	-2.726,81%	2,79%	US$ 409,36 B	6,45%
NVO	16,20	10,21	62,99%	2,83%	US$ 265,17 B	34,74%
MRK	12,67	4,56	36,03%	3,59%	US$ 223,87 B	28,16%
AZN	28,39	5,90	20,79%	1,83%	US$ 264,46 B	16,23%
BMY	17,97	5,29	29,44%	5,41%	US$ 92,49 B	10,71%
GILD	19,99	7,16	35,82%	2,79%	US$ 140,30 B	24,71%
ZTS	24,61	13,09	53,20%	1,32%	US$ 65,16 B	28,00%
HALO	14,26	25,08	175,93%	0,00%	US$ 8,35 B	48,21%
REGN	13,97	2,10	15,06%	0,44%	US$ 63,00 B	31,83%
AMGN	30,70	21,58	70,29%	3,15%	US$ 160,26 B	14,67%
VRTX	28,59	6,03	21,11%	0,00%	US$ 103,65 B	31,22%
MCK	24,89	-106,90	-429,55%	0,40%	US$ 92,26 B	0,97%
CAH	26,56	-13,96	-52,54%	1,31%	US$ 36,76 B	0,60%
ADMA	17,05	8,87	52,03%	0,00%	US$ 3,53 B	43,51%
BIIB	13,23	1,33	10,08%	0,00%	US$ 23,50 B	17,46%

comparison of HZNP with indexes

If you had invested (change) 2 years years ago, ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

Dividend History HZNP

current DY: 0,00%

5-year average DY: 0,00%

no dividend paid in the period.

ABOUT THE COMPANY Horizon Therapeutics

Horizon Therapeutics Public Limited Company

Average user rating I10

4.0 (0 people)

Estados Unidos

15 years

Foundation: 2010

2011

Year of debut on the stock exchange - 14 years

1.395

Employees

The Company Horizon Therapeutics Public Limited Company (Estados Unidos), is listed on Nasdaq with a market value of $ 27,21 Billions, having a net worth of $ 5,31 Billions.

With a total of 1.395 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 3,64 Billions, which generated a profit in the amount of $ 438,00 Milhões.

As for its main indicators, the Company has a P/E ratio of 62,12, a P/BV ratio of 5,12 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker HZNP.

Market value

US$ 27,21 Billions

Net worth

US$ 5,31 Billions

US$ 5.310.959.000,00

Assets

US$ 9,30 Billions

US$ 9.298.741.000,00

Total Number of Shares

233,94 Milhões

233.935.000

Average Daily Trading Volume

US$ 2,44 Milhões

US$ 2.438.746,00

Sector

Health Care

Industry

Biotechnology

HZNP

HZNP revenue and profits

HZNP results

DRAG THE FRAME TO SEE MORE DATA

HZNP cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 763,55 51,69% (12M)

P/L

24,89

0,40%

ROE

-429,55%

P/VP

-106,90

CAH - Cardinal Health

US$ 156,88 42,09% (12M)

P/L

26,56

1,31%

ROE

-52,54%

P/VP

-13,96

JNJ - Johnson & Johnson

US$ 190,72 21,94% (12M)

P/L

17,80

2,69%

ROE

32,50%

P/VP

5,78

MRK - Merck & Co.

US$ 85,99 --18,73% (12M)

P/L

12,67

3,59%

ROE

36,03%

P/VP

4,56

ABBV - AbbVie

US$ 230,50 23,82% (12M)

P/L

108,79

2,79%

ROE

-2.726,81%

P/VP

-2.966,40

PFE - Pfizer

US$ 24,78 --8,77% (12M)

P/L

16,92

6,25%

ROE

10,33%

P/VP

1,75

AZN - AstraZeneca

US$ 84,53 11,61% (12M)

P/L

28,39

1,83%

ROE

20,79%

P/VP

5,90

BFRA - Biofrontera

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 763,55 51,69% (12 M)

P/L

24,89

0,40%

ROE

-429,55%

P/VP

-106,90

CAH - Cardinal Health

US$ 156,88 42,09% (12 M)

P/L

26,56

1,31%

ROE

-52,54%

P/VP

-13,96

JNJ - Johnson & Johnson

US$ 190,72 21,94% (12 M)

P/L

17,80

2,69%

ROE

32,50%

P/VP

5,78

MRK - Merck & Co.

US$ 85,99 --18,73% (12 M)

P/L

12,67

3,59%

ROE

36,03%

P/VP

4,56

ABBV - AbbVie

US$ 230,50 23,82% (12 M)

P/L

108,79

2,79%

ROE

-2.726,81%

P/VP

-2.966,40

PFE - Pfizer

US$ 24,78 --8,77% (12 M)

P/L

16,92

6,25%

ROE

10,33%

P/VP

1,75

AZN - AstraZeneca

US$ 84,53 11,61% (12 M)

P/L

28,39

1,83%

ROE

20,79%

P/VP

5,90

Frequently Asked Questions

What is the price of Horizon Therapeutics (HZNP) today?

The price of Horizon Therapeutics (HZNP) today is US$ 0,00, with a variation of 0% compared to the last year. The price of Horizon Therapeutics (HZNP) started the year trading around US$ 0,00 and today it is at US$ 0,00. Follow the real-time price chart, the historical price of Horizon Therapeutics (HZNP), and stock data from Ibovespa and international markets.

When does Horizon Therapeutics (HZNP) pay dividends?

Horizon Therapeutics (HZNP) did not distribute dividends in the last year.

Horizon Therapeutics (HZNP) is it worth it?

Currently, Horizon Therapeutics (HZNP) is priced at US$ 0,00, with a P/E of 62,12%, representing a deviation of 53,60% from its historical average P/E. In the last year, the stock showed a variation of 0% in its price and distributed US$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was 0,00%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy stocks of Horizon Therapeutics (HZNP)?

Investing in stocks of Horizon Therapeutics (HZNP) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 stocks of Horizon Therapeutics (HZNP) yield today?

The yield of Horizon Therapeutics (HZNP) was 0,00% in the last month, 0,00% in the last year and 0,00% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of US$ 0,00 in dividends, um Dividend Yield de 0,00%.

If you wanted to buy 100 stocks of Horizon Therapeutics (HZNP) today, the total investment would be US$ 0,00, based on the current price of US$ 0,00.

If past performance were to repeat, the return on your investment would be:

In 1 year: US$ 0,00
In 5 years: US$ 0,00
In 10 years: 0,00

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

HZNP

Horizon Therapeutics Public Limited Company

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

Profitability of HZNP

check out the fundamentals of Horizon Therapeutics shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

Graham's Fair Price

If you had invested (change) 2 years years ago, ago, today you would have

current DY: 0,00%

5-year average DY: 0,00%

ABOUT THE COMPANY Horizon Therapeutics

Horizon Therapeutics Public Limited Company

Estados Unidos

15 years

2011

1.395

PROFIT X PRICE HZNP

HZNP results

HZNP cash flow

evolution of assets - HZNP

HZNP balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

ABBV - AbbVie

PFE - Pfizer

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

ABBV - AbbVie

PFE - Pfizer

AZN - AstraZeneca

Frequently Asked Questions